netFormulary NHS
Herefordshire & Worcestershire
Medicines and Prescribing Committee
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
02.01  Positive inotropic drugs
02.01.01  Cardiac glycosides
Digoxin
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
02.01.01  Digoxin-specific antibody
Digibind
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
02.01.02  Phosphodiesterase type-3 inhibitors
Milrinone
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
02.02  Diuretics to top
02.02.01  Thiazides and related diuretics
Bendroflumethiazide
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Indapamide
View adult BNF View SPC online View childrens BNF
Formulary
Green

2.5mg immediate release tablets

 
 
Metolazone
View adult BNF View SPC online View childrens BNF
Formulary
Amber

Metolazone 5mg tablets are now discontinued. 2.5mg tablets are available as an unlicensed 'special'.

 
 
02.02.02  Loop diuretics
Furosemide
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Bumetanide
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
02.02.03  Potassium-sparing diuretics and aldosterone antagonists
Amiloride Hydrochloride
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
02.02.03  Aldosterone antagonists
Eplerenone
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Spironolactone
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
Link  MHRA Drug Safety Update (Dec 2016): Spironolactone and renin-angiotensin system drugs in heart failure: risk of potentially fatal hyperkalaemia
 
02.02.04  Potassium-sparing diuretics with other diuretics to top
Co-amilofruse (furosemide and amiloride)
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Co-amilozide (amiloride and hydrochlorothiazide)
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
02.02.05  Osmotic diuretics
Mannitol
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red

Commissioned by NHSE as a contrast media in radiography.

 
 
02.02.06  Mercurial diuretics
02.02.07  Carbonic anhydrase inhibitors
02.02.08  Diuretics with potassium
02.03  Anti-arrhythmic drugs to top
02.03.01  Management of arrhythmias
02.03.02  Drugs for arrhythmias
02.03.02  Supraventricular arrhythmias
Adenosine
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Dronedarone
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Amber

Only following specialist initiation and in line with NHSE&I "Items which should not routinely be prescribed in primary care" and NICE TA197.


See also HWCCG Dronedarone Prescribing Guidelines and MHRA guidance on cardiovascular, hepatic and pulmonary toxicity.

 
Link  HW CCG Dronedarone Prescribing Guidelines
Link  MHRA Drug safety update Dronedarone (Multaq): cardiovascular, hepatic and pulmonary adverse events – new restrictions and monitoring requirements October 2014
Link  NHSE/I: Items which should not routinely be prescribed in primary care: Guidance for CCGs
Link  NICE TA 197 Dronedarone for the treatment of non-permanent atrial fibrilation (Update Dec 2012)
 
02.03.02  Supraventricular and ventricular arrhythmias
Amiodarone tablets
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Amber

Only following specialist initiation and in line with NHSE&I "Items which should not routinely be prescribed in primary care".

See also HWCCG Amiodarone Prescribing Guidance

 
Link  HW CCG Amiodarone Prescribing Guidance
Link  NHSE/I: Items which should not routinely be prescribed in primary care: Guidance for CCGs
 
Amiodarone injection
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Disopyramide capsules
View adult BNF View SPC online View childrens BNF
Formulary
Amber
 
 
Disopyramide injection
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Flecainide Acetate tablets
View adult BNF View SPC online View childrens BNF
Formulary
Amber
 
 
Flecainide Acetate injection
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Propafenone Hydrochloride tablets
View adult BNF View SPC online View childrens BNF
Formulary
Amber
 
 
02.03.02  Ventricular arrhythmias to top
Lidocaine Hydrochloride
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Mexiletine Hydrochloride
View adult BNF View SPC online View childrens BNF
Unlicensed Drug Unlicensed
Amber
 
 
02.04  Beta-adrenoceptor blocking drugs
Atenolol
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Propranolol Hydrochloride
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Bisoprolol Fumarate
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Carvedilol
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Labetalol Hydrochloride
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Metoprolol Tartrate
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Nebivolol
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Sotalol Hydrochloride
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Amber

For anti-arrythmic use only

 
 
Esmolol (injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
02.05  Drugs affecting the renin-angiotensin system and some other antihypertensive drugs
Sacubitril/valsartan  (Entresto®)
View adult BNF View SPC online View childrens BNF
Formulary
Amber

In line with NICE TA388

 
Link  NICE TA388 Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction
 
02.05.01  Vasodilator antihypertensive drugs
Hydralazine Hydrochloride
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Sodium Nitroprusside
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Tolazoline
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Iloprost
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red

Unlicensed use in vascular patients. Manufacturer form must be completed by prescribing consultant and pharmacist.

 
 
02.05.02  Centrally acting antihypertensive drugs
Methyldopa
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Moxonidine
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
02.05.03  Adrenergic neurone blocking drugs to top
02.05.04  Alpha-adrenoceptor blocking drugs
Doxazosin
View adult BNF View SPC online View childrens BNF
Formulary
Green

EXCLUDING modified-release tablets

 
 
Prazosin
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
02.05.04  Phaeochromocytoma
Phentolamine
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Phenoxybenzamine Hydrochloride
View adult BNF View SPC online View childrens BNF
Formulary
Amber
 
 
02.05.05  Drugs affecting the renin-angiotensin system
02.05.05  Heart Failure
02.05.05.01  Angiotensin-converting enzyme inhibitors (ACE inhibitors) to top
Ramipril
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Lisinopril
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Perindopril Erbumine
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Captopril oral solution
View adult BNF View SPC online View childrens BNF
Formulary
Amber
 
 
Enalapril
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
02.05.05.02  Angiotensin-II receptor antagonists
Candesartan Cilexetil
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Irbesartan
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Losartan Potassium
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Valsartan
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
02.05.05.03  Renin inhibitors
02.06  Nitrates, calcium-channel blockers, and potassium-channel activators
02.06  Angina
02.06.01  Nitrates to top
Glyceryl Trinitrate
View adult BNF View SPC online View childrens BNF
Formulary
Green

SL spray and SL tablets

 
 
Isosorbide Mononitrate
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Isosorbide Mononitrate Modified Release
View adult BNF View SPC online View childrens BNF
Formulary
Green

Preferred modified-release brands:

    • Chenydur XL® 60mg tablets
    • Monomil XL® 60mg tablets
    • Elantan LA® 25mg capsules
    • Elantan LA® 50mg capsules


 
 
Isosorbide Dinitrate intravenous infusion (Isoket®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
02.06.02  Calcium-channel blockers
Amlodipine
View adult BNF View SPC online View childrens BNF
Formulary
Green

First choice CCB for hypertension

 
 
Diltiazem Hydrochloride
View adult BNF View SPC online View childrens BNF
Formulary
Green

60 mg tablet formulations are safely interchangeable but should be prescribed as Tildiem® brand as it is more cost effective.

Other strengths are NOT interchangeable and should always be prescribed by brand name.

Preferred once daily modified-release brand:

  • Zemtard XL® capsules
  • Viazem XL®capsules for 360mg strength

Preferred twice daily modified release brand:

  • Angitil SR® capsules

 

 
 
Lercanidipine
View adult BNF View SPC online View childrens BNF
Formulary
Green

HWMPC July 2020: Added to the formulary as an alternative to amlodipine where it may be of benefit for patients who experience ankle oedema.

 
 
Nifedipine Modified Release
View adult BNF View SPC online View childrens BNF
Formulary
Green

Modified release nifedipine should be prescribed by brand because different versions may not have the same clinical effect.

Preferred once daily modified-release brands:

  • Coracten XL® capsules
  • Adipine XL® tablets

Preferred twice daily modified release brands:

  • Coracten SR® capsules
  • Adipine MR® tablets
 
 
Nimodipine
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red

See BNF for restricted indications.

 
 
Verapamil Hydrochloride
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
02.06.03  Other anitanginal drugs
Nicorandil
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
Link  MHRA Drug Alert (Nov 15): Nicorandil – risk of ulcerations and secondary complications
 
Ivabradine
View adult BNF View SPC online View childrens BNF
Formulary

AmberChronic Heart Failure: In line with NICE TA 267.

AmberAngina: In line with SPC

RedPrior to planned CT angiogram in asthmatic patients (Specialist initiation only): Ivabradine 5mg bd for 3 days. This off-label, non-formulary indication is used in patients who cannot have beta blockers, as they must have a heart rate less than 60 for the CT to give good enough images. Full 3 day supply must be prescribed and dispensed to patients by secondary care  i.e. not for primary care prescribing.

 

 
Link  NICE TA267 - Ivabradine for Treating Chronic Heart Failure
 
Ranolazine
View adult BNF View SPC online View childrens BNF
Formulary
Amber
 
 
02.06.04  Peripheral vasodilators and related drugs
Naftidrofuryl Oxalate
View adult BNF View SPC online View childrens BNF
Formulary
Green

In line with NICE TA223.

 
Link  NICE TA223 Treatment of intermittent claudication in people with peripheral arterial disease
 
02.06.04  Other preparations used in peripheral vascular disease
02.07  Sympathomimetics to top
02.07.01  Inotropic sympathomimetics
Dobutamine Injection
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Dopamine Hydrochloride Injection
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Dopexamine Hydrochloride Injection
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Isoprenaline Sulphate Injection
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
02.07.02  Vasoconstrictor sympathomimetics
Ephedrine Hydrocloride
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Metaraminol
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Noradrenaline / Norepinephrine
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Phenylephrine Hydrochloride
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Midodrine Tablets
View adult BNF View SPC online View childrens BNF
Formulary
Amber
 
 
02.07.03  Cardiopulmonary resuscitation
Adrenaline / Epinephrine (Adrenaline / Epinephrine 1 in 10000, dilute)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
02.08  Anticoagulants and protamine
Idarucizumab (Praxbind®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
02.08.01  Parenteral anticoagulants to top
02.08.01  Heparin
Heparin Sodium IV
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Heparin Calcium Subcutaneous
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red

On Consultant advice only

 
 
02.08.01  Low molecular weight heparins
Dalteparin Sodium
View adult BNF View SPC online View childrens BNF
Formulary
Amber
 
 
Enoxaparin sodium (Clexane®Inhixa®)
View adult BNF View SPC online View childrens BNF
Formulary
Green

PRESCRIBE BY BRAND

Please ensure all prescribers are aware of the specific instructions relating to the prescribing of enoxaparin and ensure relevant staff understand the administration differences between Clexane® and Inhixa® and can counsel patients accordingly.

 
 
02.08.01  Heparinoids
Argatroban
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
02.08.01  Hirudins
Bivalirudin
View adult BNF View SPC online View childrens BNF
Formulary
Red

In line with NICE TA 230

 
Link  NICE TA230 Bivalirudin for the treatment of ST-segment-elevation myocardial infarction
 
02.08.01  Heparin flushes to top
Heparin Sodium Flushes
View adult BNF View SPC online View childrens BNF
Formulary
Amber

For use in long line and central lines only

 
 
02.08.01  Epoprostenol
Epoprostenol (Flolan®)
View adult BNF View SPC online View childrens BNF
Formulary
Red

ITU use only in haemofiltration

 
 
02.08.01  Fondaparinux
Fondaparinux Sodium (Arixtra®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
02.08.02  Oral anticoagulants
Warfarin Sodium
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
Link  COVID 19 Interim Publication: Safe Switching of Warfarin to DOACs - Clinical Guidance
Link  MHRA Drug Dafety Update (Jul 16): Warfarin: reports of calciphylaxis
 
Edoxaban
View adult BNF View SPC online
Formulary
Green

Edoxaban should be prescribed as first line DOAC in the treatment of non-valvular AF.

 
Link  NICE TA354 Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism
Link  NICE TA355 Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation
 
Apixaban
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
Link  NICE TA245 Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults
Link  NICE TA275 Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation
Link  NICE TA341 Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism
 
Dabigatran
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
Link  NICE TA157 Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults September 2008
Link  NICE TA249 Atrial fibrilation - dabigatran etexilate March 2012
Link  NICE TA327 - an option for treatment and for secondary prevention of recurrent DVT & PE.
 
Rivaroxaban
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
Link  MHRA - Drug Safety Update (Oct 2018): Rivaroxaban (Xarelto▼) after transcatheter aortic valve replacement: increase in all-cause mortality, thromboembolic and bleeding events in a clinical trial
Link  MHRA Drug Safety Update (Jul 19): Rivaroxaban (Xarelto▼): Reminder that 15 mg and 20 mg tablets should be taken with food
Link  NICE TA 607: Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease
Link  NICE TA170 Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults April 2009
Link  NICE TA256 Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrilation. May 2012
Link  NICE TA261 Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism
Link  NICE TA287 Pulmonary embolism and recurrent venous thromboembolism
Link  NICE TA335 Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome
 
Phenindione
View adult BNF View SPC online View childrens BNF
Formulary
Amber

Only when warfarin or DOAC not tolerated / clinically appropriate

 
 
Acenocoumarol
View adult BNF View SPC online View childrens BNF
Formulary
Amber

Only when warfarin, phenindione or DOAC not tolerated / clinically appropriate

 
 
02.08.02  Stroke prevention in AF
02.08.02  Atrial Fibrillation to top
02.08.02  VTE treatment
02.08.02  VTE prophylaxis in hip/knee surgery
02.08.02  VTE Prophylaxis
02.08.03  Protamine sulphate
Protamine Sulphate Injection
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
02.09  Antiplatelet drugs to top
Aspirin 75mg dispersible tablets
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Clopidogrel
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
Link  MHRA Drug Safety Update (April 2010): Clopidogrel and proton pump inhibitors: interaction—updated advice
Link  NICE TA210: Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events
 
Ticagrelor
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
Link  NICE TA236 Ticagrelor for the treatment of acute coronary syndromes
Link  NICE TA420 Ticagrelor for preventing atherothrombotic events after myocardial infarction
 
Dipyridamole M/R Capsules
View adult BNF View SPC online View childrens BNF
Formulary
Amber
 
Link  TA210: Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events
 
Abciximab (ReoPro®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Link  NICE TA47: Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes
 
Eptifibatide (Integrilin®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Link  NICE TA47: Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes
 
Prasugrel
View adult BNF View SPC online View childrens BNF
Formulary
Amber
 
Link  NICE TA317 Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes
 
Tirofiban (Aggrastat®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Link  NICE TA47: Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes
 
02.10  Stable angina, acute coronary syndromes, and fibrinolysis
02.10.01  Management of stable angina and acute coronary syndromes
02.10.02  Fibrinolytic drugs
Alteplase (Actilyse®)
View adult BNF View SPC online View childrens BNF
Formulary
Red

In line with NICE TA52 and TA264

 
Link  NICE TA264 Alteplase for treating acute ischaemic stroke
Link  NICE TA52 Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction
 
Reteplase (Rapilysin®)
View adult BNF View SPC online View childrens BNF
Formulary
Red

In line With NICE TA52

 
Link  NICE TA52 Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction
 
Streptokinase
View adult BNF View SPC online View childrens BNF
Formulary
Red

In line With NICE TA52

 
Link  NICE TA52 Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction
 
Tenecteplase (Metalyse®)
View adult BNF View SPC online View childrens BNF
Formulary
Red

In line With NICE TA52

 
Link  NICE TA52 Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction
 
02.11  Antifibrinolytic drugs and haemostatics
Tranexamic Acid Tablets
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Tranexamic Acid Injection
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Dried Prothrombin Complex (Beriplex® )
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
02.11  Blood-related products to top
Fresh Frozen Plasma
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
02.12  Lipid-regulating drugs
Alirocumab (Praluent®)
View adult BNF View SPC online View childrens BNF
Formulary
Red

In line with NICE TA393

 
Link  Cytokine Modulator Pathway for the Management of Primary Hypercholesterolaemia or Mixed Dyslipidaemia in Adults
Link  NICE TA393 Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
 
Evolocumab (Repatha®)
View adult BNF View SPC online View childrens BNF
Formulary
Red

In line with NICE TA394

 
Link  Cytokine Modulator Pathway for the Management of Primary Hypercholesterolaemia or Mixed Dyslipidaemia in Adults
Link  NICE TA394 Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
 
02.12  Bile acid sequestrants
Colesevelam (Cholestagel®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Amber

Consultant initiation in patients with terminal ileal resection where cholestyramine is not tolerated and can be continued by GP if patient shows response beyond one month.

 
 
Colestyramine
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
02.12  Ezetimibe
Ezetimibe
View adult BNF View SPC online View childrens BNF
Formulary
Green

In line with NICE TA385

 
Link  NICE TA385 Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia
 
02.12  Fibrates
Bezafibrate
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Fenofibrate
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
02.12  Statins to top
Simvastatin
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Atorvastatin Tablets
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Atorvastatin chewable tablets
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Green

For patients unable to swallow ordinary tablets who would otherwise need a liquid.

 
 
Fluvastatin
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Pravastatin Sodium
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
 
Rosuvastatin
View adult BNF View SPC online View childrens BNF
Formulary
Green

Not for primary prevention; only for secondary prevention in those whose response is not considered adequate for other statins, despite maximum tolerated doses; or where there is contraindication to other statins due to interactions. 

 
 
02.12  Nicotinic acid group
02.12  Omega-3 fatty acid compounds
Omega-3-acid ethyl esters (Omacor®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Amber

Following consultant lipidologist initiation for refractory hypertriglyceridaemia only.


Should not be routinely be prescribed in primary care, in line with national NHSE&I guidance.

 
Link  NHSE/I: Items which should not routinely be prescribed in primary care: Guidance for CCGs
Link  Omega-3 preparations - Position Statement
 
02.12  PCSK9 inhibitors
02.12  Other lipid modifying agents
02.13  Local sclerosants to top
Ethanolamine Oleate
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
Lauromacrogol 400 / polidocanol  (Aethoxysklerol®)
View adult BNF View SPC online View childrens BNF
Formulary
Red

APC MAR 20: Alternative sclerotherapy treatment option of varicose veins of the lower extremities (in line with commissioning policy), for a specific cohort of patients where the efficacy and safety profile makes it a preferred treatment choice over sodium tetradecyl sulfate

 
 
Sodium tetradecyl sulphate
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
 
 ....
 Non Formulary Items
aliskiren  (Rasilex®)

View adult BNF View SPC online View childrens BNF
Non Formulary

Aliskiren should not be routinely be prescribed in primary care - See NHSE&I: Items that should not routinely be prescribed in primary care.

Link  NHSE/I: Items which should not routinely be prescribed in primary care: Guidance for CCGs
Ambrisentan

View adult BNF View SPC online View childrens BNF
Non Formulary

NHS England Commissioned Specialist Centres Only

Link  NHSE Pulmonary Hypertension Commissioning Policy
Antithrombin III  (Kybemin®)

View adult BNF View SPC online View childrens BNF
Non Formulary Commissioned by NHS England-to be used as per BCSH Guidelines
Bosentan  (Tracleer®)

View adult BNF View SPC online View childrens BNF
Non Formulary

NHS England Commissioned Specialist Centres Only.

Link  NHSE Pulmonary Hypertension Commissioning Policy
Doxazosin modified release

View adult BNF View SPC online View childrens BNF
Non Formulary

Should not be routinely be prescribed in primary care, in line with national NHSE&I guidance.

Link  NHSE/I: Items which should not routinely be prescribed in primary care: Guidance for CCGs
Factor IX Fraction, Dried

View adult BNF View SPC online View childrens BNF
Non Formulary

Commissioned by NHS England-to be used as per BCSH Guidelines

Factor VIIa (Recombinant)  (Novo 7®)

View adult BNF View SPC online View childrens BNF
Non Formulary

Commissioned by NHS England-to be used as per BCSH Guidelines

Factor VIII Fraction, Dried

View adult BNF View SPC online View childrens BNF
Non Formulary

Commissioned by NHS England-to be used as per BCSH Guidelines

Factor VIII Inhibitor Bypassing Factor

View adult BNF View SPC online View childrens BNF
Non Formulary

Commissioned by NHS England-to be used as per BCSH Guidelines

Felodipine

View adult BNF View SPC online View childrens BNF
Non Formulary

HWMPC July 20: All strengths of felodipine removed from the H&W formulary due to increased acquistion costs. Clinicians asked to switch patients taking 5mg and 10mg felodipine to amlodipine during their medication review and review those patients taking 2.5mg, increasing the dose to the licensed maintenance dose where possible. 

Human Fibrinogen  (Riastap®)

View adult BNF View SPC online View childrens BNF
Non Formulary

Commissioned by NHS England-to be used as per BCSH Guidelines

Indapamide MR

View adult BNF View SPC online View childrens BNF
Non Formulary
Omega-3-Marine Triglycerides  (Maxepa®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Pentoxifylline

View adult BNF View SPC online View childrens BNF
Non Formulary
Perindopril arginine  (Coversyl®Arginine)

View adult BNF View SPC online View childrens BNF
Non Formulary

Should not be routinely be prescribed in primary care, in line with national NHSE&I guidance.

Link  NHSE/I: Items which should not routinely be prescribed in primary care: Guidance for CCGs
Perindopril arginine and indapamide  (Coversyl Arginine® Plus)

View adult BNF View SPC online View childrens BNF
Non Formulary

Should not be routinely be prescribed in primary care, in line with national NHSE&I guidance.

Link  NHSE/I: Items which should not routinely be prescribed in primary care: Guidance for CCGs
Protein C Concentrate  (Ceprotin®)

View adult BNF View SPC online View childrens BNF
Non Formulary

Commissioned by NHS England-to be used as per BCSH Guidelines

Sildenafil

View adult BNF View SPC online View childrens BNF
Non Formulary

For pulmonary hypertension - NHS England Commissioned Specialist Centres Only

Link  NHSE Pulmonary Hypertension Commissioning Policy
Sildenafil  (Revatio®)

View adult BNF View SPC online View childrens BNF
Non Formulary

NHS England Commissioned Specialist Centres Only

Link  NHSE Pulmonary Hypertension Commissioning Policy
Simvastatin and Ezetimibe  (Inegy®)

View adult BNF View SPC online View childrens BNF
Non Formulary
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Secondary care only, not to be prescribed in primary care.   

Amber 2

Specialist initiation with shared care guidance Medicines which should be initiated in secondary care by the specialist with follow-on prescription and monitoring according to a specific Shared Care (SC) Guideline. Prescribing may be continued in primary care in line with a shared care guideline   

Amber with Shared Care

Specialist initiation with shared care guidance Medicines which should be initiated in secondary care by the specialist with follow-on prescription and monitoring according to a specific Shared Care (SC) Guideline. Prescribing may be continued in primary care in line with a shared care guideline   

Amber

Considered suitable for primary care prescribing following specialist initiation/recommendation.  

Green

Considered appropriate for prescribing in both secondary and primary care. Suitable for initiation in primary care.   

netFormulary